AS
Amit Singal
Research areas: Medicine · Hepatology · Hepatocellular Carcinoma Treatment and Prognosis · Hepatitis B Virus Studies · Liver Disease Diagnosis and Treatment
0000-0002-1172-3971
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (200)
- Surveillance for Hepatocellular Carcinoma in Patients at High Risk Save
- Clinical utilization of testing for cell-free DNA in hepatocellular cancer Save
- Evaluating a Polygenic Risk Score for Hepatocellular Carcinoma in Multiethnic Cirrhosis Patients in Texas Save
- The future of blood-based biomarkers in liver cancer Save
- Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of Ascelia‐Manganese‐Based MRI Contrast Agent (ACE‐MBCA) in Adult Subjects With and Without Hepatic Impairment Save
- Multi-target blood test for hepatocellular carcinoma early detection: A cross-sectional analysis of the prospective ALTUS study Save
- BEACON-HCC: Best evidence and North American consensus on treatment allocation for hepatocellular carcinoma Save
- Contemporary global epidemiology of cirrhosis Save
- Impact of Social Determinants of Health on Hepatocellular Carcinoma Surveillance Receipt and Early Detection Save
- Net benefit of surveillance varies by hepatocellular carcinoma risk in patients with cirrhosis Save
- Reply to: “Beyond binary classification of non-proportional hazards: Methodological considerations for interpreting pivotal HCC trials” Save
- Longitudinal Assessment of Clinical Risk Scores for Hepatocellular Carcinoma in Patients With Cirrhosis Save
- Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic Save
- Addition of AFP Improves Sensitivity of Ultrasound for Early-Stage HCC Detection in Patients With Cirrhosis Save
- Updated Epidemiology of Gastrointestinal Cancers in the Asia‐Pacific: Evidence From GBD 2021 and GLOBOCAN 2022 Save
- Hepatocellular carcinoma: Clinical trials to watch Save
- Very Early‐Stage Detection Is Associated With Improved Survival in Patients With Unifocal Hepatocellular Carcinoma Save
- Immune-Related Adverse Events Are Associated With Improved Outcomes After Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis Save
- Novel biomarkers for early detection of HCC in patients with MASLD or ALD Save
- Reply to “Interpreting projected gastrointestinal cancer burden in Africa: The case of liver cancer” Save